In order to align with Shanghai's goal of accelerating the construction of a scientific and technological innovation center, a high-level research institution dedicated to virology source innovation and clinical translation will be built in Shanghai.

The Wyss Institute and Harvard University said on Tuesday that they have licensed protein detection technology to Spear Bio.

On December 28,Shanghai Universal Biotech Co.,Ltd. was listed on the Shenzhen Stock Exchange (SZSE) ChiNext, stock code: 301166. The issue price is 86.06 yuan/share, and the opening price is 92 yuan/share.

Austrian biopharma firm Viravaxx said on Tuesday that it is collaborating with the Medical University of Vienna to create a platform for diagnostic and vaccine research into COVID-19. The collaborators will use a protein microarray comprisi